| Acarbose | | For treatment and Management of Diabetes type II (Used in combination therapy as a Second or third line agent) |
| Chlorpropamide | | For managing hyperglycemia in Non-insulin-Dependent diabetes mellitus (NIDDM). |
| Gliclazide | | For the treatment of Diabetes mellitus |
| Glimepiride | | For concomitant use with insulin for the treatment of noninsulin-Dependent (Type II) diabetes mellitus; For the treatment of |
| Glipizide | | For the treatment of hyperglycemia in Non-insulin-Dependent diabetes mellitus (NIDDM) |
| Glyburide | | For treatment and management of Type II diabetes mellitus |
| Insulin | | |
| Insulin, porcine | | For treatment of diabetes (type I and II) |
| Insulin Glargine recombinant | | For treatment of diabetes (type I and II) |
| Insulin Lyspro recombinant | | For treatment of diabetes (type I and II) |
| Insulin recombinant | | For treatment of diabetes (type I and II) |
| Nateglinide | | Fro the treatment of type II diabetes (combination therapy when administered with metformin) |
| Phenformin | | For the reatment of type II diabetes mellitus |
| Pioglitazone | | Treatment of Type II diabetes mellitus |
| Repaglinide | | For the treatment of Type II diabetes mellitus |
| Rosiglitazone | | For the treatment of Type II diabetes mellitus |
| Tolbutamide | | For the management of hyperglycemia in non-insulin-Dependent diabetes mellitus |
| Troglitazone | | For the treatment of Type II diabetes mellitus |
